EAM
VERA icon

EFG Asset Management’s Vera Therapeutics VERA Stock Holding History

EFG Asset Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-109,281
Closed -$2.62M – 189
2025
Q1 		$2.62M Buy
109,281
+36,121
+49% +$1.16M 0.44% 90
2024
Q4 		$3.09M Buy
73,160
+27,192
+59% +$1.2M 0.42% 91
2024
Q3 		$2.03M Buy
45,968
+14,524
+46% +$551K 0.34% 130
2024
Q2 		$1.14M Buy
31,444
+21,101
+204% +$837K 0.2% 175
2024
Q1 		$446K Buy
+10,343
New +$369K 0.08% 188

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

EFG Asset Management's VERA Position: Q2 2025 in Review

EFG Asset Management sold out of Vera Therapeutics (VERA) in Q2 2025, closing a stake of 109,281 shares — an estimated $2.62M sold.

EFG Asset Management first reported a position in VERA in Q1 2024 and held it in 5 quarters. The position peaked at $3.09M in Q4 2024. 172 funds tracked by Wall St. Rank hold VERA as of Q2 2025.

  • EFG Asset Management reported no remaining Vera Therapeutics position as of Q2 2025 after selling out during the quarter.
  • EFG Asset Management sold 109,281 Vera Therapeutics shares in Q2 2025, an estimated $2.62M.
  • EFG Asset Management first reported a position in Vera Therapeutics in Q1 2024 and held it in 5 quarters.
  • EFG Asset Management's Vera Therapeutics position peaked at $3.09M in Q4 2024.
  • 172 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2025.

Based on EFG Asset Management's 13F filing for Q2 2025, filed 6 Aug 2025.